Impact of Down syndrome on the performance of neonatal screening assays for severe primary immunodeficiency diseases.
- nov 2014
- Esther de Vries
- 1
- 3443
ARTIKEL: Verstegen RH, Borte S, Bok LA, van Zwieten PH, von Döbeln U, Hammarström L, de Vries E. J Allergy Clin Immunol. 2014 Apr;133(4):1208-11.
Bijlagen
| titel | toegevoegd | door | opties | |
|---|---|---|---|---|
| Verstegen_et_al_JACI.pdf | nov 2014 |  |
Verken
Protective but lower levels of antibodies after single conjugated meningococcal serogroup C vaccination in children with Down syndrome.
nov 2014POSTER: Kusters MA, Jol-van der Zijde CM, Gijsbers R, de Vries E. European Society for Paediatric Infe...
Incidence of respiratory symptoms in children with Down syndrome: feasibility of a web-based parent-reported prospective study.
nov 2014POSTER: Verstegen RHJ, de Vries E. European Society for Paediatric Infectious Diseases, Milan, Italy, ...
Functionality of the pneumococcal antibody response in Down syndrome subjects.
nov 2014ARTIKEL: Kusters MAA, Manders NCC, de Jong BAW, van Hout RWNM,RijkersGT, de Vries E. Vaccine. 2013 Dec...